Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year?

Company Overview - Coya Therapeutics, Inc. (COYA) is a stock within the Medical sector, which comprises 1000 individual stocks and holds a Zacks Sector Rank of 2, indicating strong performance relative to other sectors [2][3]. Performance Analysis - Coya Therapeutics has shown a year-to-date return of approximately 7.7%, outperforming the Medical sector's average return of -2.9% [4]. - The Zacks Consensus Estimate for COYA's full-year earnings has increased by 7.8% over the past quarter, reflecting improved analyst sentiment and a stronger earnings outlook [4]. Industry Context - Coya Therapeutics is part of the Medical - Biomedical and Genetics industry, which includes 508 stocks and currently ranks 76 in the Zacks Industry Rank. This industry has experienced an average loss of 4% year-to-date, indicating that COYA is performing better than its peers [6]. - In comparison, another stock in the Medical sector, Doximity (DOCS), has a year-to-date return of 6.2% and a Zacks Rank of 2, with a consensus EPS estimate increase of 13.2% over the past three months [5][6].